Study protocol for a phase II randomised, double-blind, placebo-controlled trial of perampanel as an antiepileptogenic treatment following acute stroke.

John-Paul NicoloZhibin ChenBradford MoffatDavid K WrightBenjamin SinclairRebecca GlarinAndrew NealVincent ThijsUdaya SeneviratneBernard YanGeoffrey CloudTerence J O'BrienPatrick Kwan

Published in: BMJ open (2021)

ACTRN12618001984280; Pre-results.

Keyphrases

double blind
phase ii
placebo controlled
clinical trial
open label
phase iii
study protocol
randomized controlled trial